Evidence map›Paper›PMID 21273200›Full record

ReviewEuropean heart journal2011

Renovascular hypertension: screening and modern management.

Iris Baumgartner, Lilach O Lerman

Open access · bronzeAbstract readReview
In one paragraph

Review in European heart journal, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Renal resistive index for renovascular hypertension: In the quest of the Holy Grail.Journal of clinical hypertension (Greenwich, Conn.) · 2018
    Article
  7. Review
  8. Article
  9. Renal fibromuscular dysplasia.BMJ case reports · 2015
    Article
  10. Observational
  11. Review
  12. Article
  13. Review
  14. Radionuclides in nephrourology, Part 2: pitfalls and diagnostic applications.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2014
    Review
  15. Article
  16. Renovascular hypertension associated with pseudoaneurysm following blunt trauma.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2013
    Article
  17. Article
  18. Review
  19. Review
  20. Diagnostic criteria for renovascular disease: where are we now?Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Iris BaumgartnerDepartment of Clinical and Interventional Angiology, Swiss Cardiovascular Center, University of Bern, Switzerland.
Lilach O Lerman
Mayo Clinic · USUniversity of Bern · CH

Funding

Tissue Oxygenation in Human Renovascular HypertensionP01HL085307 · NHLBI · MAYO CLINIC ROCHESTER · PI ROMERO, JUAN C · 2007 to 2011
$10.4M
CT imaging for the assessment of kidney injury distal to renal artery stenosisR01DK073608 · NIDDK · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O · 2006 to 2015
$3.1M
CT Evaluation of the Myocardial Effects of Risk FactorsR01HL077131 · NHLBI · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O · 2004 to 2013
$2.8M
Autologous Progenitor Cells Delivery in Renovascular DiseaseR21DK077013 · NIDDK · MAYO CLINIC ROCHESTER · PI LERMAN, LILACH O · 2008 to 2009
$416k
NHLBI NIH HHS HL085307NHLBI NIH HHS HL77131NHLBI NIH HHS R01 HL077131NIDDK NIH HHS DK73608NIDDK NIH HHS DK77013
6 · The paper itself

Abstract

The diagnosis and management of patients with renovascular disease and hypertension continue to elude healthcare providers. The advent of novel imaging and interventional techniques, and increased understanding of the pathways leading to irreversible renal injury and renovascular hypertension, have ushered in commendable attempts to optimize and fine-tune strategies to preserve or restore renal function and control blood pressure. Large randomized clinical trials that compare different forms of therapy, and smaller trials that test novel experimental treatments, will hopefully help formulate innovative concepts and tools to manage the patient population with atherosclerotic renovascular disease.

Indexed as

AtherosclerosisHypertension, RenovascularRenal Artery ObstructionAngiography, Digital SubtractionAngioplasty, BalloonAngiotensin Receptor AntagonistsDrug-Eluting StentsEarly DiagnosisFibromuscular DysplasiaHemodynamicsHumansMagnetic Resonance ImagingRenin-Angiotensin SystemReperfusionTomography, X-Ray ComputedUltrasonography, DopplerAngiotensin Receptor Antagonists

Identifiers

PMID21273200
PMCPMC3128298
OpenAlexW2091621557

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.